How to join PharmaSources as a freelance writer?
Recent years have seen innovation in many fields, such as software and computing, which has re-shaped and re-branded various process industries, including pharmaceuticals. These new technologies have enabled pharma industries to enhance product quality and reduce costs. It has also enabled pharma manufacturers to decrease time to market, which could previously take years.
For the pharmaceutical industry, these latest trends have changed the paradigm of every field – from drug discovery to drug manufacturing, procurement to warehousing and from drug manufacturing to marketing.
What are the latest trends in pharma industry that helps increasing the patient’s life?
Let’s look at some latest trends in pharmaceutical industry and how these have increased the efficiency of final product.
Increased use of CDMOs for manufacturing business
CDMO stands for Contract Development and Manufacturing Organization and provides pharma drug discovery, development, manufacturing and marketing facilities to pharma manufacturers with approved product lists. Still, they lack manufacturing facilities to manufacture their own. CDMOs have no approved product list and are not allowed to market and distribute any pharma product under their brand name.
CDMOs are full-scale manufacturing facilities on their own, having their quality department. They support pharma manufacturers that cannot produce their own facilities for any reason, such as cost issues, under-capacity resources or urgency in product demand.
Some benefits a CDMO offer for a particular pharma manufacturing organization include the following.
Helps to deal with pharmaceutical aging facilities
One of many essential components in pharmaceutical product manufacturing is the facility where a pharma process is carried out. There is a huge cost for constructing and maintaining these facilities. Additionally, some products also require dedicated manufacturing facilities, including the building.
However, as time passes, and if these facilities are not updated, they become outdated and are considered ageing facilities. In these facilities, pharma manufacturing operations are not allowed.
CDMOs are beneficial in these cases because they keep their manufacturing facilities updated due to their diverse nature of operations. So, if a pharma manufacturer decides to manufacture a new product that requires heavy investment for constructing facilities, CDMOs can be used to avoid heavy spending.
Effectively manage source
CDMO have expertise in sourcing. They can effectively source raw materials and other ingredients if one source becomes obsolete or dead.
They have flexible capacity
Since CDMOs often have diverse portfolios of pharma customers, they can usually manufacture any batch size of any type. This can be advantageous for pharma manufacturers over-burdened with their customer orders.
Strong supply chain foot print
CDMOs have excellent supply chain facilities that enable them to supply pharma products to every customer and diverse location services. They can also provide logistic support for sensitive products such as temperature sensitive. They are also able to provide on-time delivery and hard-to-reach areas.
Cloud based operations
Cloud computing is a new technology where computing services are available over the internet, irrespective of devices, associated hardware and location. The services can range from storage, monito...
(All Rights Reserved)